AMN Healthcare Services Inc (AMN) stock plummeted 5.22% in the pre-market trading session on Monday, following an analyst downgrade and a price target cut.
Citizens JMP, a research firm, lowered its price target on AMN Healthcare to $33 from $34 while maintaining an Outperform rating. The analyst cited AMN's weaker-than-expected fourth-quarter revenue performance as the reason for the price target revision.
While there was another positive report on the healthcare sector from analysts at JMP, it did not directly mention AMN Healthcare and likely had little impact on the stock's movement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.